PREDICT: a checklist for preventing preanalytical diagnostic errors in clinical trials
Abstract: Although the importance of guaranteeing a high level of preanalytical quality in routine diagnostic testing has already been largely acknowledged over the past decades, minor emphasis is currently being placed on the fact that accurate performance and standardization of many preanalytical activities are also necessary prerogatives of clinical trials. Reliable evidence exists that clear indications on how to manage the different preanalytical steps are currently lacking in many clinical trials protocols, nor have detailed authoritative documents been published or endorsed on this matter to the best of our knowledge. To fill this gap, the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for Preanalytical Phase (WG-PRE) will provide here a specific checklist for preventing preanalytical diagnostic errors in clinical trials (PREDICT), especially focused on covering the most important preanalytical aspects of blood sample management in clinical studies, and thus encompassing test selection, patient preparation, sample collection, management and storage, sample transportation, as well as specimen retrieval before testing. The WG-PRE members sincerely hope that these recommendations will provide a useful contribution for increasing the success rate in clinical trials.
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
PREDICT: a checklist for preventing preanalytical diagnostic errors in clinical trials ; volume:58 ; number:4 ; year:2020 ; pages:518-526 ; extent:9
Clinical chemistry and laboratory medicine ; 58, Heft 4 (2020), 518-526 (gesamt 9)
- Creator
- DOI
-
10.1515/cclm-2019-1089
- URN
-
urn:nbn:de:101:1-2022061215234644577697
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
11.02.20252026, 10:52 PM CET
Data provider
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lippi, Giuseppe
- von Meyer, Alexander
- Cadamuro, Janne
- Simundic, Ana-Maria
Other Objects (12)
The EFLM strategy for harmonization of the preanalytical phase
The preanalytical phase in the era of high-throughput genetic testing. What the future holds
Breve actualización sobre el diagnóstico de la enfermedad por coronavirus 2019 (COVID-19)
Brief update on coronavirus disease 2019 (COVID-19) diagnostics
Upper respiratory samples pooling for screening SARS-CoV-2 infection: ready for the prime time?
The impact of COVID-19 on citations of laboratory medicine journals
Weighting healthcare efficiency against available resources: value is the goal
Sepsis biomarkers: past, present and future
Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19): Part II
Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19)—Part III
Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19)
Laboratory Testing in the Era of Direct or Non–Vitamin K Antagonist Oral Anticoagulants: A Practical Guide to Measuring Their Activity and Avoiding Diagnostic Errors
The EFLM strategy for harmonization of the preanalytical phase
The preanalytical phase in the era of high-throughput genetic testing. What the future holds
Breve actualización sobre el diagnóstico de la enfermedad por coronavirus 2019 (COVID-19)
Brief update on coronavirus disease 2019 (COVID-19) diagnostics
Upper respiratory samples pooling for screening SARS-CoV-2 infection: ready for the prime time?
The impact of COVID-19 on citations of laboratory medicine journals
Weighting healthcare efficiency against available resources: value is the goal
Sepsis biomarkers: past, present and future
Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19): Part II
Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19)—Part III
Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19)
Laboratory Testing in the Era of Direct or Non–Vitamin K Antagonist Oral Anticoagulants: A Practical Guide to Measuring Their Activity and Avoiding Diagnostic Errors
The EFLM strategy for harmonization of the preanalytical phase
The preanalytical phase in the era of high-throughput genetic testing. What the future holds
Breve actualización sobre el diagnóstico de la enfermedad por coronavirus 2019 (COVID-19)
Brief update on coronavirus disease 2019 (COVID-19) diagnostics
Upper respiratory samples pooling for screening SARS-CoV-2 infection: ready for the prime time?
The impact of COVID-19 on citations of laboratory medicine journals
Weighting healthcare efficiency against available resources: value is the goal
Sepsis biomarkers: past, present and future
Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19): Part II
Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19)—Part III
Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19)